PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.38) per share. This is a 31.03 percent decrease over losses of $(0.29) per share from the same period last year.
Apple’s Next ‘Industry-Shifting Product’ Arrives Monday, Says Gurman Ahead Of WWDC’s Unveiling Of MR Headset: ‘It’s Hard To Bet Against The Company’
Apple, Inc.’s (NASDAQ:AAPL) mixed-reality headset is widely expected to launch on the first day of the company’s annual…
